Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
87.03
+1.29 (1.50%)
At close: Nov 3, 2026, 4:00 PM EST
88.32
+1.29 (1.48%)
Pre-market: Nov 4, 2026, 8:41 AM EST
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Mirum Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $153.43. The average 1-year stock price forecast is 76.30% higher than the current stock price, while the lowest is $118 (+35.59%) and the highest is $200 (+129.81%).
Price Target: $153.43 (+76.30%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 10 | 10 | 10 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $200 → $202 | Buy | Reiterates | $200 → $202 | +132.10% | Nov 4, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $144 → $167 | Buy | Maintains | $144 → $167 | +91.89% | Nov 4, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $140 → $145 | Buy | Maintains | $140 → $145 | +66.61% | Oct 21, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $136 → $156 | Buy | Maintains | $136 → $156 | +79.25% | Oct 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 13, 2026 |
Financial Forecast
Revenue This Year
717.10M
from 521.31M
Increased by 37.56%
Revenue Next Year
833.62M
from 717.10M
Increased by 16.25%
EPS This Year
-15.23
from -0.47
EPS Next Year
-0.17
from -15.23
EPS and Forward PE are based on non-GAAP adjusted numbers.